We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
Cap. Flow
-$1.56B
Cap. Flow %
-3.42%
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$352M
2
KR icon
Kroger
KR
+$279M
3
T icon
AT&T
T
+$235M
4
INTC icon
Intel
INTC
+$217M
5
EW icon
Edwards Lifesciences
EW
+$212M

Sector Composition

Rank Sector Weight
1 Financials 19.08%
2 Technology 16.14%
3 Healthcare 15.45%
4 Consumer Discretionary 9.74%
5 Consumer Staples 5.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWACW
3926
CALL
DELISTED
BETTER WORLD ACQUISITION CORP. Warrants
BWACW
-305,180
Closed -$3.15M
DSEY
3927
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
-619,537
Closed -$4.09M
XM
3928
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
-96,836
Closed -$1.21M
RXDX
3929
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-311,670
Closed -$8.8M
LITTW
3930
CALL
DELISTED
Logistics Innovation Technologies Corp. Warrant
LITTW
-234,497
Closed -$2.28M
CS
3931
DELISTED
Credit Suisse Group
CS
-172,600
Closed -$980K
ATIP.WS
3932
CALL
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
-338,197
Closed -$478K
WEJOW
3933
CALL
DELISTED
Wejo Group Limited Warrant
WEJOW
-517,085
Closed -$616K
DBD
3934
DELISTED
Diebold Nixdorf Incorporated
DBD
-447,360
Closed -$1.01M
JNCE
3935
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-39,339
Closed -$119K
FRC
3936
DELISTED
First Republic Bank
FRC
-5,200
Closed -$750K
HZON.WS
3937
CALL
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
-431,655
Closed -$4.28M
OIG
3938
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
-5,721
Closed -$144K
PEARW
3939
CALL
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
-300,000
Closed -$462K
ARVL
3940
DELISTED
Arrival Ordinary Shares
ARVL
-27,542
Closed -$2.18M
PLXP
3941
DELISTED
PLx Pharma Inc. Common Stock
PLXP
-40,154
Closed -$98K
GIA.WS
3942
CALL
DELISTED
GigCapital 5, Inc. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GIA.WS
-400,000
Closed -$4.02M
APEN
3943
DELISTED
Apollo Endosurgery, Inc.
APEN
-58,923
Closed -$215K
RAM
3944
DELISTED
Aries I Acquisition Corporation Class A Ordinary Share
RAM
-89,613
Closed -$903K
NOGN
3945
DELISTED
Nogin, Inc. Common Stock
NOGN
-53,722
Closed -$10.7M
CNCE
3946
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-89,146
Closed -$374K
HPX
3947
DELISTED
HPX Corp.
HPX
-1,194,226
Closed -$11.9M
OIIM
3948
DELISTED
02Micro International
OIIM
-13,173
Closed -$49K
COUP
3949
DELISTED
Coupa Software Incorporated
COUP
-320,079
Closed -$18.3M
ZGN.WS
3950
CALL
DELISTED
Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share
ZGN.WS
-98,382
Closed -$1.04M

Similar funds

Marshall Wace's Q3 2022 Portfolio in Review

As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.

  • Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
  • Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
  • Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
  • Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
  • Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
  • Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
  • Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.